US3091572A
(en)
|
1962-07-16 |
1963-05-28 |
Schering Corp |
Gentamycin and method of production
|
US3136704A
(en)
|
1962-12-05 |
1964-06-09 |
Schering Corp |
Manufacture of gentamycin
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
GB2046092B
(en)
|
1979-03-05 |
1983-11-02 |
Toyama Chemical Co Ltd |
Pharmaceutical composition containing a lysophospholid and a phospholipid
|
HU184141B
(en)
|
1979-12-27 |
1984-07-30 |
Human Oltoanyagtermelo |
Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
|
US4451447A
(en)
|
1980-03-31 |
1984-05-29 |
Bristol-Myers Company |
Pharmaceutical formulations
|
DE3269611D1
(en)
|
1981-07-02 |
1986-04-10 |
Hoffmann La Roche |
Process for preparing liposome solutions
|
US4547490A
(en)
|
1981-12-31 |
1985-10-15 |
Neomed, Inc. |
Synthetic whole blood and a method of making the same
|
US4522803A
(en)
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
US4684625A
(en)
|
1982-07-08 |
1987-08-04 |
Syntex (U.S.A.) Inc. |
Method for enhancing the anti-infective activity of muramyldipeptide derivatives
|
US4588578A
(en)
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
US4981692A
(en)
|
1983-03-24 |
1991-01-01 |
The Liposome Company, Inc. |
Therapeutic treatment by intramammary infusion
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
US5030453A
(en)
|
1983-03-24 |
1991-07-09 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
US4515736A
(en)
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
US5059591B1
(en)
|
1983-05-26 |
2000-04-25 |
Liposome Co Inc |
Drug preparations of reduced toxicity
|
CA1237670A
(en)
|
1983-05-26 |
1988-06-07 |
Andrew S. Janoff |
Drug preparations of reduced toxicity
|
US4606939A
(en)
|
1983-06-22 |
1986-08-19 |
The Ohio State University Research Foundation |
Small particle formation
|
CA1237671A
(en)
|
1983-08-01 |
1988-06-07 |
Michael W. Fountain |
Enhancement of pharmaceutical activity
|
GB8322178D0
(en)
|
1983-08-17 |
1983-09-21 |
Sterwin Ag |
Preparing aerosol compositions
|
EP0153955A1
(en)
|
1983-09-06 |
1985-09-11 |
Health Research, Inc. |
Liposome delivery method for decreasing the toxicity of an antitumor drug
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
US4963367A
(en)
|
1984-04-27 |
1990-10-16 |
Medaphore, Inc. |
Drug delivery compositions and methods
|
US5008050A
(en)
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
SE8403905D0
(sv)
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
US4880635B1
(en)
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
US5077056A
(en)
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
US5736155A
(en)
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
JPS63500175A
(ja)
|
1985-05-22 |
1988-01-21 |
リポソ−ム テクノロジ−,インコ−ポレイテツド |
リポソ−ム吸入法および吸入システム
|
CA1314481C
(en)
|
1986-12-23 |
1993-03-16 |
Marcel B. Bally |
Liposomal preparation and antibiotic
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
US5409704A
(en)
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US5059421A
(en)
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
JP2579625B2
(ja)
|
1985-07-05 |
1997-02-05 |
ザ リポソ−ム カンパニ−,インコ−ポレイテツド |
改良された取り込み効率を有するマルチラメラリポソ−ム
|
JPH0665648B2
(ja)
|
1985-09-25 |
1994-08-24 |
塩野義製薬株式会社 |
白金系抗癌物質の安定な凍結真空乾燥製剤
|
US5041278A
(en)
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
US4861580A
(en)
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
US5041581A
(en)
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
US5023087A
(en)
|
1986-02-10 |
1991-06-11 |
Liposome Technology, Inc. |
Efficient method for preparation of prolonged release liposome-based drug delivery system
|
US4833134A
(en)
|
1986-08-19 |
1989-05-23 |
Takeda Chemical Industries, Ltd. |
Cephem compounds
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
US4933121A
(en)
|
1986-12-10 |
1990-06-12 |
Ciba Corning Diagnostics Corp. |
Process for forming liposomes
|
US5320906A
(en)
|
1986-12-15 |
1994-06-14 |
Vestar, Inc. |
Delivery vehicles with amphiphile-associated active ingredient
|
US5723147A
(en)
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
MX9203808A
(es)
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
US5616334A
(en)
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
US4857311A
(en)
|
1987-07-31 |
1989-08-15 |
Massachusetts Institute Of Technology |
Polyanhydrides with improved hydrolytic degradation properties
|
US4895452A
(en)
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5269979A
(en)
|
1988-06-08 |
1993-12-14 |
Fountain Pharmaceuticals, Inc. |
Method for making solvent dilution microcarriers
|
IL91664A
(en)
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
BE1001869A3
(fr)
|
1988-10-12 |
1990-04-03 |
Franz Legros |
Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
|
US4952405A
(en)
|
1988-10-20 |
1990-08-28 |
Liposome Technology, Inc. |
Method of treating M. avium infection
|
US4906476A
(en)
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5006343A
(en)
|
1988-12-29 |
1991-04-09 |
Benson Bradley J |
Pulmonary administration of pharmaceutically active substances
|
US5843473A
(en)
|
1989-10-20 |
1998-12-01 |
Sequus Pharmaceuticals, Inc. |
Method of treatment of infected tissues
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5820848A
(en)
|
1990-01-12 |
1998-10-13 |
The Liposome Company, Inc. |
Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
JPH05507090A
(ja)
|
1990-05-08 |
1993-10-14 |
リポサーム テクノロジー インコーポレイテッド |
直接噴霧乾燥された薬剤/脂質粉末組成物
|
US5614216A
(en)
|
1990-10-17 |
1997-03-25 |
The Liposome Company, Inc. |
Synthetic lung surfactant
|
IT1245761B
(it)
|
1991-01-30 |
1994-10-14 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
|
US5770563A
(en)
|
1991-12-06 |
1998-06-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
CA2126101A1
(en)
|
1991-12-17 |
1993-06-24 |
Robert J. Debs |
Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
AU3244393A
(en)
|
1992-12-02 |
1994-06-22 |
Vestar, Inc. |
Antibiotic formulation and process
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
JPH09502700A
(ja)
|
1993-04-02 |
1997-03-18 |
ザ リポソーム カンパニー、インコーポレーテッド |
リポソームの製造方法
|
CA2120197A1
(en)
|
1993-04-02 |
1994-10-03 |
Kenji Endo |
Stable aqueous dispersions containing liposomes
|
US5759571A
(en)
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
CA2166465C
(en)
|
1993-07-08 |
2003-10-14 |
Laura M. Edgerly-Pflug |
Method of controlling the size of liposomes
|
US5766627A
(en)
|
1993-11-16 |
1998-06-16 |
Depotech |
Multivescular liposomes with controlled release of encapsulated biologically active substances
|
EP0741580A4
(en)
|
1993-12-14 |
2001-07-11 |
Univ Johns Hopkins Med |
CONTROLLED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCES FOR IMMUNOTHERAPY
|
CA2190121A1
(en)
|
1994-03-15 |
1995-09-21 |
Edith Mathiowitz |
Polymeric gene delivery system
|
US5610198A
(en)
|
1994-03-18 |
1997-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
|
US5550109A
(en)
|
1994-05-24 |
1996-08-27 |
Magainin Pharmaceuticals Inc. |
Inducible defensin peptide from mammalian epithelia
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5543152A
(en)
|
1994-06-20 |
1996-08-06 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
US5993850A
(en)
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
US5753613A
(en)
|
1994-09-30 |
1998-05-19 |
Inex Pharmaceuticals Corporation |
Compositions for the introduction of polyanionic materials into cells
|
US5508269A
(en)
|
1994-10-19 |
1996-04-16 |
Pathogenesis Corporation |
Aminoglycoside formulation for aerosolization
|
AR002009A1
(es)
|
1994-12-22 |
1998-01-07 |
Astra Ab |
Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
|
US5662929A
(en)
|
1994-12-23 |
1997-09-02 |
Universite De Montreal |
Therapeutic liposomal formulation
|
US5972379A
(en)
|
1995-02-14 |
1999-10-26 |
Sequus Pharmaceuticals, Inc. |
Liposome composition and method for administering a quinolone
|
US5800833A
(en)
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
US5855610A
(en)
|
1995-05-19 |
1999-01-05 |
Children's Medical Center Corporation |
Engineering of strong, pliable tissues
|
DE69620136T2
(de)
|
1995-06-06 |
2002-08-01 |
Bayer Ag |
Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
|
US5643599A
(en)
|
1995-06-07 |
1997-07-01 |
President And Fellows Of Harvard College |
Intracellular delivery of macromolecules
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
EP0830381A4
(en)
|
1995-06-09 |
2000-11-22 |
William N Drohan |
CHITINE HYDROGELS, PRODUCTION METHOD AND USE
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
AU730969B2
(en)
|
1995-10-19 |
2001-03-22 |
University Of Washington |
Discrete-length polyethylene glycols
|
GB9602969D0
(en)
|
1996-02-13 |
1996-04-10 |
The Technology Partnership Plc |
Liquid supply apparatus
|
US5840702A
(en)
|
1996-03-22 |
1998-11-24 |
Uab Research Foundation |
Cystic fibrosis treatment
|
US5875776A
(en)
|
1996-04-09 |
1999-03-02 |
Vivorx Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6132765A
(en)
|
1996-04-12 |
2000-10-17 |
Uroteq Inc. |
Drug delivery via therapeutic hydrogels
|
DK0910382T3
(da)
|
1996-04-26 |
2003-10-06 |
Genaera Corp |
Squalamin i kombination med andre anticancermidler til behandling af tumorer
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6503881B2
(en)
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
ES2208946T3
(es)
|
1996-08-23 |
2004-06-16 |
Sequus Pharmaceuticals, Inc. |
Liposomas que contienen un compuesto de cisplatino.
|
US5837282A
(en)
|
1996-10-30 |
1998-11-17 |
University Of British Columbia |
Ionophore-mediated liposome loading
|
CA2275889C
(en)
|
1996-12-30 |
2008-03-18 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
US6451784B1
(en)
|
1996-12-30 |
2002-09-17 |
Battellepharma, Inc. |
Formulation and method for treating neoplasms by inhalation
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6106858A
(en)
|
1997-09-08 |
2000-08-22 |
Skyepharma, Inc. |
Modulation of drug loading in multivescular liposomes
|
US6090407A
(en)
|
1997-09-23 |
2000-07-18 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anti-cancer drugs
|
KR100883149B1
(ko)
*
|
1997-10-22 |
2009-02-10 |
젠스 포니카우 |
진균류에 의한 점막염을 국소 치료하기 위한 항진균제의용도
|
US6051251A
(en)
|
1997-11-20 |
2000-04-18 |
Alza Corporation |
Liposome loading method using a boronic acid compound
|
AU1656799A
(en)
|
1997-12-12 |
1999-07-05 |
Inex Pharmaceuticals Corp. |
Cationic drugs encapsulated in anionic liposomes
|
US6468532B1
(en)
|
1998-01-22 |
2002-10-22 |
Genentech, Inc. |
Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
|
US20020086852A1
(en)
|
1998-05-14 |
2002-07-04 |
Cantor Jerome O. |
Method for treating respiratory disorders associated with pulmonary elastic fiber injury
|
KR100613706B1
(ko)
|
1998-05-27 |
2006-08-21 |
유로-셀띠끄 소시에떼 아노님 |
항염증용 제제, 특히 귀 및/또는 상부호흡기의 창상치료촉진용 약제 및/또는 소독 약제
|
US6200598B1
(en)
|
1998-06-18 |
2001-03-13 |
Duke University |
Temperature-sensitive liposomal formulation
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
CA2340118C
(en)
|
1998-08-12 |
2009-01-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
|
AU766703B2
(en)
|
1998-11-12 |
2003-10-23 |
Frank G Pilkiewicz |
An inhalation system
|
US6855296B1
(en)
|
1998-11-13 |
2005-02-15 |
Optime Therapeutics, Inc. |
Method and apparatus for liposome production
|
DE69938875D1
(es)
|
1998-11-13 |
2008-07-17 |
William A Heriot |
|
JP2002532430A
(ja)
|
1998-12-17 |
2002-10-02 |
パソゲネシス コーポレイション |
エアゾール化抗生物質を用いる重篤な慢性気管支炎(気管支拡張症)の処置方法
|
US6211162B1
(en)
|
1998-12-30 |
2001-04-03 |
Oligos Etc. Inc. |
Pulmonary delivery of protonated/acidified nucleic acids
|
AU773515B2
(en)
|
1999-02-08 |
2004-05-27 |
Alza Corporation |
Method for controlling liposome size
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
IL146872A0
(en)
|
1999-06-03 |
2002-08-14 |
|
Methods and compositions for modulating cell proliferation and cell death
|
AU769357B2
(en)
|
1999-07-15 |
2004-01-22 |
University Of British Columbia, The |
Methods for preparation of lipid-encapsulated therapeutic agents
|
US6352996B1
(en)
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
US6235177B1
(en)
|
1999-09-09 |
2001-05-22 |
Aerogen, Inc. |
Method for the construction of an aperture plate for dispensing liquid droplets
|
US6962151B1
(en)
|
1999-11-05 |
2005-11-08 |
Pari GmbH Spezialisten für effektive Inhalation |
Inhalation nebulizer
|
DE19953317C1
(de)
|
1999-11-05 |
2001-02-01 |
Pari Gmbh |
Inhalationsvernebler
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
AU777338B2
(en)
|
1999-12-04 |
2004-10-14 |
Research Development Foundation |
Carbon dioxide enhancement of inhalation therapy
|
US7025988B2
(en)
|
2000-02-04 |
2006-04-11 |
Lipoxen Technologies Limited |
Liposomes
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
MXPA02010884A
(es)
|
2000-05-05 |
2003-03-27 |
Aerogen Ireland Ltd |
Aparato y metodo para el suministro de medicamentos al sistema respiratorio.
|
US7600511B2
(en)
|
2001-11-01 |
2009-10-13 |
Novartis Pharma Ag |
Apparatus and methods for delivery of medicament to a respiratory system
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
US7100600B2
(en)
|
2001-03-20 |
2006-09-05 |
Aerogen, Inc. |
Fluid filled ampoules and methods for their use in aerosolizers
|
US6948491B2
(en)
|
2001-03-20 |
2005-09-27 |
Aerogen, Inc. |
Convertible fluid feed system with comformable reservoir and methods
|
US6338859B1
(en)
|
2000-06-29 |
2002-01-15 |
Labopharm Inc. |
Polymeric micelle compositions
|
US6521736B2
(en)
|
2000-09-15 |
2003-02-18 |
University Of Massachusetts |
Amphiphilic polymeric materials
|
HUP0303719A2
(hu)
|
2000-10-16 |
2004-03-01 |
Neopharm, Inc. |
Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
|
US6497901B1
(en)
|
2000-11-02 |
2002-12-24 |
Royer Biomedical, Inc. |
Resorbable matrices for delivery of bioactive compounds
|
EP1203614A1
(de)
|
2000-11-03 |
2002-05-08 |
Polymun Scientific Immunbiologische Forschung GmbH |
Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln
|
ATE396707T1
(de)
|
2000-12-01 |
2008-06-15 |
Biomira Inc |
Herstellung grosser liposome durch infusion in peg
|
EP1355628A2
(en)
|
2001-02-01 |
2003-10-29 |
Board of Regents, The University of Texas System |
Stabilised polymeric aerosols for pulmonary gene delivery
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
US20030060451A1
(en)
|
2001-05-29 |
2003-03-27 |
Rajneesh Taneja |
Enhancement of oral bioavailability of non-emulsified formulations of prodrug esters with lecithin
|
EP1269993A1
(en)
|
2001-06-21 |
2003-01-02 |
Applied NanoSystems B.V. |
Delivery of small hydrophilic molecules packaged into lipid vesicles
|
WO2003000236A1
(en)
|
2001-06-23 |
2003-01-03 |
Lyotropic Therapeutics, Inc |
Particles with improved solubilization capacity
|
US7063860B2
(en)
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
JP2005502653A
(ja)
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
US20030096774A1
(en)
|
2001-11-21 |
2003-05-22 |
Igor Gonda |
Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same
|
JP2005514393A
(ja)
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
WO2003059424A1
(en)
|
2002-01-15 |
2003-07-24 |
Aerogen, Inc. |
Methods and systems for operating an aerosol generator
|
JP2005530704A
(ja)
|
2002-03-05 |
2005-10-13 |
トランセイブ, インク. |
細胞内感染を予防及び治療するための吸入システム
|
WO2004002453A1
(en)
|
2002-06-28 |
2004-01-08 |
Protiva Biotherapeutics Ltd. |
Method and apparatus for producing liposomes
|
KR20050038011A
(ko)
|
2002-08-02 |
2005-04-25 |
트랜세이브, 인코포레이티드 |
백금 응집체 및 이의 제조 방법
|
AU2003268087A1
(en)
|
2002-08-23 |
2004-03-11 |
Ian Ma |
Liposomal gemcitabine compositions for better drug delivery
|
KR100489701B1
(ko)
|
2002-10-09 |
2005-05-16 |
주식회사 태평양 |
고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
ES2686361T3
(es)
*
|
2002-10-29 |
2018-10-17 |
Insmed Incorporated |
Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
|
US7879351B2
(en)
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
WO2004047801A2
(en)
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
US7968115B2
(en)
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
US6900184B2
(en)
|
2003-04-14 |
2005-05-31 |
Wyeth Holdings Corporation |
Compositions containing pipercillin and tazobactam useful for injection
|
CA2527625A1
(en)
|
2003-05-30 |
2004-12-23 |
Alza Corporation |
Method of pulmonary administration of an agent
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
US20050214224A1
(en)
|
2003-11-04 |
2005-09-29 |
Nektar Therapeutics |
Lipid formulations for spontaneous drug encapsulation
|
US7452524B2
(en)
|
2004-01-27 |
2008-11-18 |
Gilead Sciences, Inc. |
Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
|
US7556799B2
(en)
|
2004-03-30 |
2009-07-07 |
Relypsa, Inc. |
Ion binding polymers and uses thereof
|
JP4452799B2
(ja)
|
2004-07-14 |
2010-04-21 |
独立行政法人産業技術総合研究所 |
コアセルベートを活用したリポソームの製造方法
|
JP2006263054A
(ja)
|
2005-03-23 |
2006-10-05 |
Konica Minolta Sensing Inc |
呼吸器系疾患関連解析データの取得方法、オキシメータシステム及びその動作プログラム、オキシメータ並びに酸素補給システム
|
EP1712220A1
(en)
|
2005-04-15 |
2006-10-18 |
PARI GmbH Spezialisten für effektive Inhalation |
Pharmaceutical aerosol composition
|
DE102005034403B3
(de)
|
2005-07-22 |
2007-02-22 |
Airbus Deutschland Gmbh |
Führungsmittel für eine Vorrichtung zur Herstellung von Faservorformlingen im TFP-Verfahren für Verbundbauteile
|
CA2616877C
(en)
|
2005-07-27 |
2014-01-28 |
Protiva Biotherapeutics, Inc. |
Systems and methods for manufacturing liposomes
|
EP1926424B1
(en)
|
2005-09-07 |
2009-08-19 |
Philips Intellectual Property & Standards GmbH |
System and method for inductively measuring the bio-impedance of a conductive tissue
|
KR100705981B1
(ko)
|
2005-10-12 |
2007-04-10 |
주식회사 리제론 |
인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물
|
PL1962805T3
(pl)
|
2005-12-08 |
2017-01-31 |
Insmed Incorporated |
Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych
|
ES2668554T3
(es)
|
2006-04-06 |
2018-05-18 |
Insmed Incorporated |
Métodos para la encapsulación liposomal inducida por coacervación y sus formulaciones
|
WO2008039989A2
(en)
|
2006-09-28 |
2008-04-03 |
Transave, Inc. |
Formulations of dnase and methods of use thereof
|
US8071127B2
(en)
|
2006-10-24 |
2011-12-06 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US8119156B2
(en)
|
2006-10-24 |
2012-02-21 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
WO2008137917A1
(en)
|
2007-05-07 |
2008-11-13 |
Transave, Inc. |
Method of treating bacterial infections with antibacterial formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
UA27298U
(en)
|
2007-06-13 |
2007-10-25 |
|
Method for preventing pleural empyema after pneumonectomy
|
UA27804U
(en)
|
2007-07-26 |
2007-11-12 |
|
Method for preventing respiratory complications after surgery in lungs and pleura
|
RU2597842C2
(ru)
|
2010-07-12 |
2016-09-20 |
Кселлия Фармасьютикалз Апс |
Лечение легочных инфекций с помощью введения тобрамицина путем аэролизации
|
EP2457609A1
(en)
|
2010-11-24 |
2012-05-30 |
PARI Pharma GmbH |
Aerosol generator
|
JP6402097B2
(ja)
|
2012-05-21 |
2018-10-10 |
インスメッド インコーポレイテッド |
肺感染症を処置するためのシステム
|
US20160193148A1
(en)
|
2013-08-01 |
2016-07-07 |
University Of Georgia Research Foundation, Inc. |
Liposomal formulations for the treatment of bacterial infections
|